4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001423029-25-000005
Chief Executive Officer sold 85,000 shares at an average $64.04 ($5,443,462)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-17 | Sale : show line 1 in the form | −46,287 | $63.55 | $2,941,539 | 3,870,670 | D |
| 2025-12-17 | Sale : show line 2 in the form | −35,750 | $64.51 | $2,306,233 | 3,834,920 | D |
| 2025-12-17 | Sale : show line 3 in the form | −982 | $65.53 | $64,350 | 3,833,938 | D |
| 2025-12-17 | Sale : show line 4 in the form | −1,981 | $66.30 | $131,340 | 3,831,957 | D |
| Open-market sales · 85,000 sh · avg $64.04 · $5,443,462 | ||||||
Loading xslF345X05/wk-form4_1766188590.xml…